Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.

Phase 2 Completed 159 enrolled UCB Pharma

RandomizedParallel-groupDouble-blindTreatment

Summary

This trial investigated the efficacy and safety of 400mg/day of lacosamide as compared to placebo in reducing the signs and symptoms of fibromyalgia syndrome.

Timeline

Start: 2006-10
Primary completion: 2008-02
Completion: 2008-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lacosamide	Other / unclassified	400 mg	—

Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.

Summary

Timeline

Drugs

Indications